Objective:To compare the performance of clinical model, radiomics model, and combined model in predicting biomarker status (IDH, MGMT, TERT, 1p/19q) of glioma.Methods: 81 glioma patients confirmed by histology were enrolled in this study. The predictive performance of each model was validated by receiver operating characteristic curve (ROC) analysis and decision curve analysis (DCA).Results: The mixed model showed the highest performance in each genic phenotype (IDH AUC = 0.93, MGMT AUC=0.88, TERT AUC=0.76, 1p/19q AUC=0.71).Conclusion: The mixed model is an effective tool to distinguish genic phenotype of brain glioma which have highest diagnostic efficiency than other models.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords